Feed:
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand? - Novo CEO to blame drug middlemen - Novo's Wegovy Puts a Higher Price on Heart Health in the US - Lilly Gains in Obesity Race With Novo as Supplies Expand - Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO - Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply - Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo - Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says - Catalent's Indiana plant to make Novo's Wegovy weight-loss drug
Novo
Bookmark
ShareKey facts
- city: Middlesex
- country: United States
- foundation year: 2016
Classified as: organization
Summary
Novo is a company. It is located in Middlesex, the United States and was founded in 2016.
Business
Novo is one of the companies in the United States and 3,466,499 companies in our database.
Stocks from Novo
Explore more on business
Talking Points:
- Online Business Banking Solutions | Novo
- Novo is an online business banking platform with no hidden fees built for small business owners. Apply for a free Novo checking account.
- The powerfully simple, award-winning banking platform for small businesses. Powered by Middlesex Federal Savings. Home of the #SmallBusinessBrave
- Powerfully simple business banking with no hidden fees - built for small business owners, freelancers, and entrepreneurs | Novo is a banking platform that ...
Learn more about talking points